Status:
UNKNOWN
Blood Glucose Monitoring on Behavior Change in Type 2 Diabetes
Lead Sponsor:
Chang Gung University of Science and Technology
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
20-90 years
Phase:
NA
Brief Summary
This purpose of this study is to investigate the effect of the self-regulation mode of continuous blood glucose monitoring on blood glucose indicators, self-efficacy, health-promoting behaviors, and m...
Detailed Description
This purpose of this study is to investigate the effect of the self-regulation mode of continuous blood glucose monitoring on blood glucose indicators, self-efficacy, health-promoting behaviors, and m...
Eligibility Criteria
Inclusion
- Diagnosed with diabetes by a doctor, and the patient is over 20 years old
- Hemoglobin A1C (HbA1C)\> 8 % or more
- Possessed self-monitoring equipment for blood glucose
- ability to use a mobile phone
- before participation, the subject fully understand the purpose and process of the research and obtain their consent.
Exclusion
- Diabetes health literacy lower than 9 points
- Those who have difficulty in visual, hearing and speech.
- Use of diuretics and steroids
Key Trial Info
Start Date :
December 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05367622
Start Date
December 1 2022
End Date
June 30 2024
Last Update
September 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHENG GUNG MEMORIAL HOSPITAL, Linkou
Taoyuan, Guishan District, Taiwan, 333